Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Quark Pharmaceuticals logo — Pioneering genetic advancements for a healthier future throu...

Quark Pharmaceuticals

Pioneering genetic advancements for a healthier future through innovative technology and impactful collaborations.

Founded 1994 9 employees Venture round Total: $61.40M Biotechnology

General Information

Company Name Quark Pharmaceuticals
Founded Year 1994
Employees 9
Industries Biotechnology
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Quark Pharmaceuticals. To contact Quark Pharmaceuticals, visit quarkpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Quark Pharmaceuticals compare?

A PDF of Quark Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Quark Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Quark Pharmaceuticals

Quark Pharmaceuticals is a biotechnology company that has been making waves since its establishment in 1994. The company has focused on developing the BiFAR technology platform for identifying new functional target genes and proteins. This innovative approach, patented by Quark, involves high-throughput gene inactivation combined with microarray detection of the functional genes responsible for phenotypes of interest. This groundbreaking technique has been instrumental in advancing gene discovery programs targeting serious diseases with significant unmet medical needs. With the rise of siRNA technology, Quark's approach is gaining traction and is rapidly becoming the preferred method for functional studies across the industry. The company has forged impactful collaborations with large pharmaceutical partners to utilize the BiFAR platform in driving genetic advancements. Notably, Quark secured a $10.00M Venture Round investment on 01 June 2010, which underscores the confidence investors have in the company's technology and potential impact. Through their pioneering efforts and innovative technology, Quark is dedicated to shaping a healthier future and addressing unmet medical needs in the field of genetics.

Business keywords: genetic advancements, technology platform, BiFAR technology, siRNA technology, gene discovery, functional studies, pharmaceutical collaborations, innovation, high-throughput gene inactivation, microarray detection, targeted gene identification, disease research, medical innovation, startup success

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $10.00M -
01 Jun 2010
Venture Round $27.00M 1
SBI Asset Management
SBI Asset Management
04 Jul 2008
Series H $13.90M 2
SBI Asset Management
SBI Asset Management, Tako Ventures
18 Apr 2008
Series G $10.50M 1
Tako Ventures
01 Jan 2006
Series F Undisclosed -
11 Sep 2001

Quark Pharmaceuticals Alternatives & Competitors

View All Alternatives
Quark Pharmaceuticals vs
Arrayit
Arrayit

Empowering scientific discovery and health advancements through innovative microarray and genotyping...

Venture round
Biotechnology, Enterprise Software
Quark Pharmaceuticals vs
AGY Therapeutics
AGY Therapeutics

Pioneering breakthrough treatments for central nervous system diseases through innovative gene disco...

Series C
Biopharma, Biotechnology
Quark Pharmaceuticals vs
GenoSensor Corporation
GenoSensor Corporation United States

We focus on genomic technologies and provide complete solutions for gene profiling and screening for...

4 employees
Biotechnology
View all alternatives

FAQ About Quark Pharmaceuticals

Pioneering genetic advancements for a healthier future through innovative technology and impactful collaborations.
Quark Pharmaceuticals was founded in 1994.
Quark Pharmaceuticals operates in Biotechnology. Its work centres on genetic advancements, technology platform, BiFAR technology and siRNA technology.
Quark Pharmaceuticals has approximately 9 employees.
Quark Pharmaceuticals has completed 5 funding rounds, raising a total of $61.40M. The latest funding stage is Venture round.
Top alternatives and competitors to Quark Pharmaceuticals include Arrayit, AGY Therapeutics, GenoSensor Corporation, siTOOLs Biotech GmbH, DyNAbind GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Quark Pharmaceuticals and Arrayit are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Quark Pharmaceuticals, https://bouncewatch.com/company/quark-pharmaceuticals, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout